Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Department of Justice
Harvard Business School
McKinsey
Colorcon
Cantor Fitzgerald
Farmers Insurance
Dow
Accenture

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070051

« Back to Dashboard

NDA 070051 describes BETAMETHASONE VALERATE, which is a drug marketed by Perrigo Uk Finco, Riconpharma Llc, Taro Pharm, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Sti Pharma Llc, Teva Pharms, and Actavis Mid Atlantic, and is included in eighteen NDAs. It is available from fourteen suppliers. Additional details are available on the BETAMETHASONE VALERATE profile page.

The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 070051
Tradename:BETAMETHASONE VALERATE
Applicant:Actavis Mid Atlantic
Ingredient:betamethasone valerate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 070051
Medical Subject Heading (MeSH) Categories for 070051
Suppliers and Packaging for NDA: 070051
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 070051 ANDA Actavis Pharma, Inc. 0472-0371 N 0472-0371-45
BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 070051 ANDA Actavis Pharma, Inc. 0472-0371 N 0472-0371-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrengthEQ 0.1% BASE
Approval Date:Oct 10, 1984TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Federal Trade Commission
Covington
QuintilesIMS
Chubb
Chinese Patent Office
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.